← Leaderboards
Galina Florova
University Of Texas Hlth Ctr At Tyler
$1,545,576
Attributed
$4,636,729
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $987.3K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,636,729 · 2
By mechanism
R01$3,755,486 · 1
R33$881,243 · 1
Top collaborators
- Steven Idell12 shared
- Andrey Komissarov12 shared
Most similar at University Of Texas Hlth Ctr At Tyler
Same institution · by research overlap
- Steven Idell$6,820,677
- Andrey Komissarov$3,479,251
- Torry Alle Tucker$3,028,800
- Melvin E Klegerman$1,249,831
- Guoqing Qian$1,204,269
Others in their field
Other Emerging Leaders on “Hemorrhage”
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$30,337,006
- Susan M Landau · University Of California Berkeley$13,571,860
- Kevin Navin Sheth · Brigham And Women'S Hospital$11,309,507
- Kristian Graugaard Andersen · Scripps Research Institute, The$8,813,527
- Daniel Sing-Kwong Tsze · Columbia University Health Sciences$6,983,130
Research focus
HemorrhageEmpyemaPleural Effusion DisorderUltrasonographyImproved OutcomePathogenesisOryctolagus CuniculusPleuralThrombolytic TherapyInjuryLungDoseFibrinLiquid SubstanceIncidenceComplicationFibrinolysisAntibioticsAcuteFda ApprovedEfficacy TestingDrainage ProcedureBiochemicalInnovation
Grant awards (12)
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$524,404
R01 · FY2024 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$535,106
R01 · FY2023 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$535,336
R01 · FY2022 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$547,086
R01 · FY2021 · HL
Optimization of a Rabbit Retained Hemothorax Model for Evidence-Based Pharmacologic Interventions$440,243
R33 · FY2021 · HL
Optimization of a Rabbit Retained Hemothorax Model for Evidence-Based Pharmacologic Interventions$441,000
R33 · FY2020 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$352,311
R01 · FY2020 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$416,339
R01 · FY2019 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$448,525
R01 · FY2018 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$364,557
R01 · FY2017 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$15,911
R01 · FY2017 · HL
Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema$15,911
R01 · FY2017 · HL